Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Other Non-Current Liabilities (2019 - 2025)

Historic Other Non-Current Liabilities for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to $319347.0.

  • Volitionrx's Other Non-Current Liabilities changed N/A to $319347.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $319347.0, marking a year-over-year change of. This contributed to the annual value of $97886.0 for FY2024, which is 2271.08% down from last year.
  • As of Q3 2025, Volitionrx's Other Non-Current Liabilities stood at $319347.0.
  • Over the past 5 years, Volitionrx's Other Non-Current Liabilities peaked at $623790.0 during Q2 2025, and registered a low of $77848.0 during Q1 2025.
  • In the last 5 years, Volitionrx's Other Non-Current Liabilities had a median value of $273138.0 in 2021 and averaged $305986.1.
  • The largest annual percentage gain for Volitionrx's Other Non-Current Liabilities in the last 5 years was 10684.87% (2023), contrasted with its biggest fall of 6987.89% (2023).
  • Volitionrx's Other Non-Current Liabilities (Quarter) stood at $253221.0 in 2021, then skyrocketed by 66.05% to $420466.0 in 2022, then crashed by 69.88% to $126649.0 in 2023, then decreased by 22.71% to $97886.0 in 2024, then soared by 226.24% to $319347.0 in 2025.
  • Its Other Non-Current Liabilities stands at $319347.0 for Q3 2025, versus $623790.0 for Q2 2025 and $77848.0 for Q1 2025.